✦ LIBER ✦

559 Individualized treatment strategy with peginterferon alpha-2b (PEG-IFN a) plus ribavirin according to early viral kinetics in hepatitis C virus (HCV) type 1 infected patients

✍ Scribed by T. Berg; V. Weich; G. Teuber; H. Klinkera; J. Rasenack; H. Hinrichsen; G.R. Pape; U. Spengler; P. Buggisch; M. Zankelg; H. Balkg; C. Sarrazin; S. Zeuzem

Book ID: 117374836
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 129 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80559-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Individualized treatment strategy accord

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1–infected patients

✍ Thomas Berg; Viola Weich; Gerlinde Teuber; Hartwig Klinker; Bernd Möller; Jens R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB 👁 1 views

Individualized treatment on the basis of early viral kinetics has been discussed to optimize antiviral therapy in chronic hepatitis C virus (HCV) infection. Individually tailored reduction in treatment duration in HCV type 1-infected patients represents one possible strategy. Four hundred thirty-thr

Early clearance kinetics of hepatitis C

Early clearance kinetics of hepatitis C virus (HCV) in patients with chronic hepatitis C under therapy with pegylated-interferon (PEG-IFN) alpha-2b or consensus-interferon (CIFN) plus ribavirin

✍ L.C. Da Silva; S.K. Ono-Nita; F.J. Carrilho; J.E.M. Medeiros-Filho; J.R.R. Pinho 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE EFFECTS OF THERAPY WITH PEGINTERFERON-ALPHA-2A VERSUS STANDARD-DOSE PEGINTERFERON-ALPHA-2B? A META-ANALYSIS COMPARING BOTH TREATMENTS PLUS RIBAVIRIN IN GENOTYPE 1/4 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION PATIENTS

✍ FMR Barros; H Cheinquer; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB